OTC : ENZB

Enzo Biochem, Inc.

$0.69887 USD

$0.0 (-0.16%)

Volume
149.65K
Average Volume
384.33K
Market Capitalization
$36.59M
P/E Ratio
-8.80
Dividend Yield
0.00%
Price Target
Year High
$1.19
Year Low
$0.25
Day High
—
Day Low
—
Payout Ratio
-$2.46
Current Ratio
$2.84
Company Overview

OTC

Kara Cannon

Medical - Diagnostics & Research

Healthcare

ENZB

125

US

USD

https://www.enzo.com

212 583 0100

294100102

0000316253

Liquidity Metrics

0.07

2.84

2.50

2.16

-2.46

Sales & Valuation

$31.91M

2.66

0.84

-6.42

-0.11

Profitability

-$0.51

-$26.08M

-31.49%

-26.37%

-9.61%

-6.81%

P/E Metrics

-8.80

0.00

0.00

Analyst Price Target & Rating

N/A

0/5

2 Analysts

%

Financial Health Scores

-4.96

3/9

$31.27M

$63.52M

$20.12M

-$8.08M

Key Metrics (TTM)

$2.9M

0.21

-0.67

2.84

-9.61%

-10.52%

-11.81%

-15.58%

326 days

Company Executives
Name Title
Kara Cannon Chief Executive Officer & Director
Patricia Eckert Chief Financial Officer
Poll Results

No votes yet today — be the first to share your view!

About Enzo Biochem, Inc. (OTC:ENZB) Stock

Enzo Biochem, Inc. operates as an integrated entity encompassing diagnostics, clinical laboratory services, and life sciences. The company is dedicated to developing, manufacturing, and commercializing diagnostic and research products, fundamentally rooted in genetic engineering, biotechnology, and molecular biology. Its operations are organized into three primary segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products division focuses on creating, producing, and distributing essential products and tools for clients engaged in clinical research, pharmaceutical development, and broader bioscience investigations. Its extensive portfolio comprises proteins, antibodies, peptides, small molecules, labeling probes, dyes, and various kits. Thes ... e offerings empower life science researchers in areas such as target identification and validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also serves scientific experts researching a wide array of health issues, including cancer, cardiovascular disorders, neurological diseases, diabetes and obesity, endocrine imbalances, infectious and autoimmune conditions, hepatotoxicity, and renal injury. Through its Clinical Laboratory Services segment, Enzo Biochem provides a spectrum of molecular and other clinical laboratory tests and procedures. These are utilized in routine patient care by medical professionals to aid in establishing or corroborating diagnoses, monitoring treatment efficacy or medication levels, and uncovering previously undiagnosed conditions. This segment operates a full-scale clinical laboratory in Farmingdale, New York, supported by a network of 30 patient service centers throughout New York and New Jersey. Furthermore, it manages specialized "STAT" or rapid response laboratories in New York City and Connecticut, along with a complete phlebotomy center and an internal logistics department. The Therapeutics segment is committed to devising innovative solutions for gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem promotes its products and services globally through a dedicated direct sales force and an established network of distributors. The company was founded in 1976 and maintains its corporate headquarters in New York, New York.

Frequently Asked Questions

What is the current Enzo Biochem, Inc. (ENZB) stock price?

Enzo Biochem, Inc.(OTC:ENZB) stock price is $0.69887 in the last trading session. During the trading session, ENZB stock reached the peak price of $1.19 while $0.252 was the lowest point it dropped to. The percentage change in ENZB stock occurred in the recent session was --0.16% while the dollar amount for the price change in ENZB stock was -$0.0.

ENZB's industry and sector of operation?

The OTC listed ENZB is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.

Who are the executives of ENZB?

Kara Cannon | Chief Executive Officer & Director
Patricia Eckert | Chief Financial Officer
|
|
|

How many employees does ENZB have?

Number of ENZB employees currently stands at 125. ENZB operates from 527 Madison Avenue, New York City, NY 10022, US.

Link for ENZB official website?

Official Website of ENZB is: https://www.enzo.com

How do I contact ENZB?

ENZB could be contacted at phone #212 583 0100 and can also be accessed through its website. ENZB operates from 527 Madison Avenue, New York City, NY 10022, US.

How many shares of ENZB are traded daily?

The average number of ENZB shares traded daily for last 3 months was 384.33K.

What is the market cap of ENZB currently?

The market value of ENZB currently stands at $36.59M with its latest stock price at $0.69887